Ligand Pharmaceuticals
LGND
LGND
203 hedge funds and large institutions have $1.12B invested in Ligand Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 78 increasing their positions, 67 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 211 → 203 (-8)
24% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 33
Holders
203
Holding in Top 10
1
Calls
$3.97M
Puts
$2.61M
Top Buyers
| 1 | +$10.5M | |
| 2 | +$7.72M | |
| 3 | +$6.1M | |
| 4 |
BlackRock
New York
|
+$4.87M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.43M |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$3.09M | |
| 3 | -$2.52M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$2.48M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.38M |